Robey, R. W., Fitzsimmons, C. M., Guiblet, W. M., Frye, W. J. E., González Dalmasy, J. M., Wang, L., Russell, D. A., Huff, L. M., Perciaccante, A. J., Ali-Rahmani, F., Lipsey, C. C., Wade, H. M., Mitchell, A. V., Maligireddy, S. S., Terrero, D., Butcher, D., Edmondson, E. F., Jenkins, L. M., Nikitina, T., … Batista, P. J. (2023). The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors. Molecular Cancer Therapeutics, 23(4), 464–477. https://doi.org/10.1158/1535-7163.mct-23-0144

Unachukwu, U., Sonett, J., Woode, D., Shiomi, T., Chada, K., & D’Armiento, J. M. (2023). Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis. Molecular Cancer Therapeutics, 22(7), 844–858. https://doi.org/10.1158/1535-7163.mct-22-0224

Sheikh, T. N., Chen, X., Xu, X., McGuire, J. T., Ingham, M., Lu, C., & Schwartz, G. K. (2021). Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors. Molecular Cancer Therapeutics, 20(12), 2362–2371. https://doi.org/10.1158/1535-7163.mct-21-0066

Scotto, L., Kinahan, C., Douglass, E., Deng, C., Safari, M., Casadei, B., Marchi, E., Lue, J. K., Montanari, F., Falchi, L., Qiao, C., Renu, N., Bates, S. E., Califano, A., & O’Connor, O. A. (2021). Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular Cancer Therapeutics, 20(8), 1422–1430. https://doi.org/10.1158/1535-7163.mct-20-0377